GMSBiotech and NuvOx presenting at National Heart, Lung, and Blood Institute San Francisco Innovation Conference

The National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute’s (NHLBI) San Francisco Innovation Conference co-hosted by  Prescience International, a firm dedicated to accelerating the commercialization and global adoption of science and technology will bring together small businesses, angel investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries onSeptember 10, 2013 at the Genentech Hall at U C San Francisco.Continue reading

Opportunity Alert – Driving Innovation in Breast Cancer: Startup Challenge

The Avon Foundation (AF), National Institutes of Health National Cancer Institute (NCI) and Center for Advancing Innovation (CAI) have partnered to launch a “first of a kind” Business Plan and Start-Up Challenge for Breast Cancer (BC) inventions that have high commercial viability and are important to public health. This challenge will accelerate the commercialization of Federal agency and AF grantee BC inventions, spur economic growth, and provide Universities a platform to further develop their entrepreneurship learning portfolio.Continue reading

NIH Awards HTG Molecular Additional $1.01M to Continue Development of Targeted Sequencing Product Concept

TUCSON, AZ–(Marketwired – Sep 4, 2013) – The National Human Genome Research Institute of the National Institutes of Health issued a Notice of Award granting a Phase II SBIR award of $1.01 million for HTG Molecular Diagnostics to continue the Nuclease Probe Mediated Sequencing Project (HTG EdgeSeq). The HTG EdgeSeq program will develop targeted sequencing products that leverage HTG Molecular Diagnostics’ core RNA analysis technology.Continue reading

Mission3 Ranks 823 on Inc. 5000 List of Fast Growing Private Companies

 

Mission3LogoFinalColor

Phoenix, AZ – September 5, 2013 – Mission3, visionaries in cloud-based software for the Life Sciences industry, today announced it has earned the rank as the 823 fastest growing private company on the Inc. 5000 2013 list.  Mission3 realized a 3 year revenue growth of 546%.  This list represents the most comprehensive look at the most important segment of the economy – America’s independent entrepreneurs. Continue reading

Ventana and EMC join forces to take digital pathology into the world of Big Data

Tucson, AZ, September 4, 2013— Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has entered into an agreement with data storage and IT infrastructure industry leader EMC Corporation (EMC) to offer a highly scalable and flexible solution to store and archive medical images as part of the VENTANA digital pathology solution for anatomical pathology labs.Continue reading